Linked Life Data

17062679

Source:http://linkedlifedata.com/resource/pubmed/id/17062679

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20 Pt 1
pubmed:dateCreated
2006-10-25
pubmed:abstractText
Hepatoma-derived growth factor (HDGF) is a nucleus-targeted growth factor playing an important role in the development and progression of cancers. This study investigated the correlation of HDGF expression and prognosis in patients with pancreatic ductal carcinoma. Patients and Methods: HDGF expression in pancreatic cancer cell lines was analyzed by Western blotting. HDGF expression was analyzed by immunohistochemistry for 50 patients with primary ductal carcinoma of the pancreas (33 male and 17 female) ranging in age from 48 to 80 years (median, 65 years) receiving surgical treatment. Cancer cells showing stronger staining than the noncancerous ducts were regarded as positive. Cases showing positive staining in < 90% and > 90% of tumor cells were regarded as HDGF labeling index (LI) levels 1 and 2, respectively. HDGF LI was determined separately for the nucleus and the cytoplasm.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6043-8
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
pubmed:affiliation
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Yamada-oka, Suita, Osaka, Japan.
pubmed:publicationType
Journal Article